18F FDG-PET/CT evaluation of histological response after neoadjuvant treatment in patients with cancer of the esophagus or gastroesophageal junction.
Conclusion Our results are similar to those of previous studies and show that changes in the rate of SUR can be used reliably to differentiate histological responders from non-responders after neoadjuvant treatment with either chemoradiotherapy or chemotherapy. Limitations of current PET technology are likely to restrict the possibility of accurately ruling out limited residual disease.
PMID: 30111193 [PubMed - as supplied by publisher]
Source: Acta Radiologica - Category: Radiology Authors: Gabrielson S, Sanchez-Crespo A, Klevebro F, Axelsson R, Albert Tsai J, Johansson O, Nilsson M Tags: Acta Radiol Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | CT Scan | Esophagectomy | Esophagus Cancer | Gastroenterology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | PET Scan | Statistics | Study